Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract

Virchows Archiv

Volumn 451, Issue 3, 2007, Pages 681-690

  Nakanishi, Kuniaki ^a   Ogata, Sho ^a   Matsuo, Hirotaka ^a   Kanai, Yoshikatsu ^b   Endou, Hitoshi ^b   Hiroi, Sadayuki ^a   Tominaga, Susumu ^a   Aida, Shinsuke ^a   Kasamatsu, Hiroyasu ^a   Kawai, Toshiaki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

4F2hc; LAT1; Prognosis; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

4F2 CELL SURFACE ANTIGEN; AMINO ACID TRANSPORTER; L TYPE AMINO ACID TRANSPORTER 1; MEMBRANE ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD98; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CELL MEMBRANE; CYTOPLASM; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; RNA, MESSENGER; UROLOGIC NEOPLASMS;

EID: 34548314415     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0457-9     Document Type: Article

References (36)

1. Campbell WA, Thompson NL (2001) Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts. J Biol Chem 276:16877-16884
2. Chillaron J, Roca R, Valencia A, Zorzano A, Palacin M (2001) Heteromeric amino acid transporters: biochemistry, genetics, and physiology. Am J Physiol Renal Physiol 281:F995-F1018
3. Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Phys Rev 70:43-77
4. Das AK, Carson CC, Bolick D, Paulson DF (1990) Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer 66:1919-1923
5. Fuchs BC, Bode BP (2005) Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15:254-266
6. Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62:2016-2020
7. Kanai Y, Endou H (2001) Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr Drug Metab 2:339-354
8. Kanai Y, Endou H (2003) Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. J Toxicol Sci 28:1-17
9. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273:23629-23632
10. Kim do K, Ahn SG, Park JC, Kanai Y, Endou H, Yoon JH (2004) Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precursor lesions. Anticancer Res 24:1671-1675
11. Kim DK, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, Tachampa K, Anzai N, Iribe Y, Endou H (2002) Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 1565:112-121
12. Kim do K, Kim IJ, Hwang S, Kook JH, Lee MC, Shin BA, Bae CS, Yoon JH, Ahn SG, Kim SA, Kanai Y, Endou H, Kim JK (2004) System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Neurosci Res 50:437-446
13. Kobayashi H, Ishii Y, Takayama T (2005) Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol 90:233-238
14. Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, Ayala G (2003) Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 23:3413-3418
15. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, Verrey F (1998) Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395:288-291
16. Matsuo H, Tsukada S, Nakata T, Chairoungdua A, Kim DK, Cha SH, Inatomi J, Yorifuji H, Fukuda J, Endou H, Kanai Y (2000) Expression of a system L neutral amino acid transporter at the blood-brain barrier. NeuroReport 11:3507-3511
17. Murphy WM, Beckwith JB, Farrow GM (1994) Tumors of the kidney, bladder, and related urinary structures. Atlas of tumor pathology, Third Series, fasc. 11. Armed Forces Institute of Pathology, Washington, DC, pp 202-219
18. Nakanishi K, Hiroi S, Tominaga S, Aida S, Kasamatsu H, Matsuyama S, Matsuyama T, Kawai T (2005) Expression of HIF-1α protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res 11:2583-2590
19. Nakanishi K, Kawai T, Sato H, Aida S, Kasamatsu H, Aurues T, Ikeda T (2000) Expression of matrix metalloproteinase-2 (MMP-2) and of membrane-type-1-matrix metalloproteinase (MT1-MMP) in transitional cell carcinoma of the upper urinary tract. Human Pathol 31:193-200
20. Nakanishi K, Kawai T, Suzuki M, Torikata C (1996) Growth factors and oncogene products in transitional cell carcinoma. Mod Path 9:292-297
21. Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1997) E-cadherin expression in upper-urinary-tract carcinoma. Int J Cancer 74:446-449
22. Nakanishi K, Kawai T, Torikata C (1996) Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Human Pathol 27:1336-1340
23. Nakanishi K, Matsuo H, Kanai Y, Endou H, Hiroi S, Tominaga S, Mukai M, Ikeda E, Ozeki Y, Aida S, Kawai T (2006) LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Virchows Arch 448:142-150
24. Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T (1998) Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract. Virchows Arch 432:445-450
25. Ohkame H, Masuda H, Ishii Y, Kanai Y (2001) Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models. J Surg Oncol 78:265-271
26. Ritchie JW, Taylor PM (2001) Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem J 356:719-725
27. Sang J, Lim YP, Panzica M, Finch P, Thompson NL (1995) TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res 55:1152-1159
28. SAS technical report P-217, SAS/STAT software (1991) The PHREG Procedure, version 6. SAS Institute, Cary, NC, p 63
29. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y (1999) Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274:19745-19751
30. Shennan DB, Thomson J, Barber MC, Travers MT (2003) Functional and molecular characteristics of system L in human breast cancer cells. Biochim Biophys Acta 1611:81-90
31. Tamai S, Masuda H, Ishii Y, Suzuki S, Kanai Y, Endou H (2001) Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size. Cancer Detec Prev 25:439-445
32. UICC (International Union Against Cancer) (2002) Renal pelvis and ureter. TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York, pp 196-198
33. Witte D, Ali N, Carlson N, Younes M (2002) Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma. Anticancer Res 22:2555-2557
34. Wolf DA, Wang S, Panzica MA, Bassily NH, Thompson NL (1996) Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56:5012-5022
35. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim JY, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T, Endou H (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514:291-302
36. Yoon JH, Kim YB, Kim MS, Park JC, Kook JK, Jung HM, Kim SG, Yoo H, Ko YM, Lee SH, Kim BY, Chun HS, Kanai Y, Endou H, Kim do K (2004) Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells. Cancer Lett 205:215-226